Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for personalized medicine
3.2.1.2 Rising research and development investments in drug discovery
3.2.1.3 Growing prevalence of chronic disease
3.2.1.4 Technological advancement in cloud computing and AI
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of informatics tools and implementation
3.2.2.2 Complexity of data integration and management
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Software
5.3 Services
Chapter 6 Market Estimates and Forecast, By Functionality, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Sequencing and target data analysis
6.3 Docking
6.4 Molecular modeling
6.5 Other functionalities
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Drug discovery
7.3 Drug development
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical and biotechnology companies
8.3 Contract research organizations (CROs)
8.4 Academic and research institutes
8.5 Other end users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Accenture
10.2 Agilent Technologies
10.3 Albany Molecular Research
10.4 Boehringer Ingelheim International
10.5 Charles River Laboratories
10.6 Collaborative Drug Discovery
10.7 Eurofins Scientific
10.8 Illumina
10.9 Jubilant Life Sciences
10.10 Novo Informatics
10.11 Oracle Corporation
10.12 Selvita
